Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,716 | -41,942 | -16,531 | 98,293 | -64,974 |
| Depreciation Amortization | -7,271 | -5,744 | -2,622 | -559 | 546 |
| Income taxes - deferred | 937 | N/A | N/A | 1,387 | -66 |
| Accounts payable and accrued liabilities | -1,061 | 4,285 | 7,745 | 4,825 | 1,261 |
| Other Working Capital | -56,602 | -51,763 | -4,248 | 80,852 | 8,549 |
| Other Operating Activity | 5,854 | -1,564 | -6,735 | -1,280 | 1,286 |
| Operating Cash Flow | $-124,860 | $-96,727 | $-22,391 | $183,519 | $-53,397 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,250 | -10,856 | -3,525 | -12,767 | -10,696 |
| Purchase Of Investment | -117,758 | -116,750 | -149,519 | -253,499 | -165,842 |
| Other Investing Activity | -5,000 | -5,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-140,007 | $-132,606 | $-153,043 | $-266,265 | $-176,538 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -286 | -134 | N/A | N/A | N/A |
| Common Stock Issued | 332 | 332 | 146 | 130,359 | 116,902 |
| Financing Cash Flow | $46 | $198 | $146 | $130,359 | $116,902 |
| Beginning Cash Position | 286,428 | 286,428 | 286,428 | 238,816 | 238,816 |
| End Cash Position | 21,607 | 57,293 | 111,140 | 286,428 | 125,783 |
| Net Cash Flow | $-264,821 | $-229,135 | $-175,289 | $47,612 | $-113,033 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,860 | -96,727 | -22,391 | 183,519 | -53,397 |
| Capital Expenditure | -17,250 | -10,856 | -3,525 | -12,767 | -10,696 |
| Free Cash Flow | -142,109 | -107,583 | -25,916 | 170,752 | -64,094 |